Ultragenyx Pharmaceutical Inc. (RARE)
RARE trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$14.92
-2.48% on the day
Market cap
$1.5B
Small cap
Revenue · 2025
$673.0M
+20.2% on 2024
Net income · 2025
-$575.0M
-85.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | RARE on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2014 |
| SEC CIK | 0001515673 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $673.0M |
| Net income | -$575.0M |
| Operating income | -$535.0M |
| Net margin | -85.4% |
| Operating margin | -79.5% |
| Revenue growth | +20.2% |
| Cash | $421.0M |
| Total assets | $1.5B |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 2.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2024-06-14 |
| Latest annual report | 10-K | 2026-02-18 |
| Latest quarterly / interim | 10-Q | 2026-08-05 |
| Latest current report | 8-K | 2026-10-14 |
| Latest proxy | DEFA14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 1,004 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -0.2% |
| 1 month | +13.7% |
| 3 months | -50.8% |
| Year to date | -35.4% |
| 1 year | -53.6% |
| From 52-week high | -59.3% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| QURE | uniQure N.V. | $21.28 | -2.56% | $1.5B |
| STOK | Stoke Therapeutics Inc. | $22.50 | -6.83% | $1.5B |
| PAHC | Phibro Animal Health Corporation | $36.81 | -1.66% | $1.5B |
| PCRX | Pacira BioSciences Inc. | $36.31 | -0.11% | $1.4B |
| INVA | Innoviva Inc. | $20.74 | -3.31% | $1.5B |
| KRSA | Korsana Biosciences Inc. | $31.66 | -6.99% | $1.4B |
| ETON | Eton Pharmaceuticals Inc. | $53.33 | -3.48% | $1.5B |
| AAPG | Ascentage Pharma Group International American Depository Shares | $15.06 | -1.63% | $1.4B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier